Skip to content

Impact of Pranayama and Mindfulness Meditation on Aggression and Anxiety among Visually Impaired Students

Nitai Biswas, D. K. Dureha

International Journal of Science and Research (IJSR) August 5, 2024 DOI: 10.21275/sr24822125041 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 30
Population Visually impaired students
Interventions Pranayama Mindfulness Meditation
Duration 13 weeks (four days per week)
Topics Anxiety Breathwork Meditation
Keywords Education
Key findings The experimental group that practiced Pranayama and Mindfulness Meditation for 13 weeks showed a significant reduction in aggression and anxiety levels compared with the control group, which received no intervention.

Abstract

This study aimed to investigate the impact of Pranayama and Mindfulness Meditation on reducing aggression and anxietyamong visually impaired students.Thirty (30) students were purposively selected and divided into an experimental group and a control group.The experimental group underwent a 13weeks (Four days per week) training regimen involving Pranayama and Mindfulness Meditation, while the control group received no intervention.Pre -test and post -test scores on aggression and anxiety were compared.The findings revealed a significant reduction in aggression and anxiety levels in the experimental group, highlighting the potential benefits of these practices for visually impaired students.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics